Nasal Decongestants - Adverse effects
Research News and Information

Monday, November 23, 2009

Parental misinterpretations of over-the-counter pediatric cough and cold medication labels.

30 May 2009 OBJECTIVE: Concerns about the safety and efficacy of over-the-counter cold medications have led to a recent US Food and Drug Administration public health advisory against their use in children <2 years of age. Our goal was to examine caregiver ... Read more...

WITHDRAWN: Nasal decongestants for the common cold.

13 Apr 2009 BACKGROUND: The common cold is a major and recurrent cause of morbidity, on average affecting children and adults two or more times each year. Nasal congestion is its commonest symptom and many therapies are marketed for its relief. There is no ... Read more...

The common cold.

30 Jan 2009 1) Most colds are due to viruses and resolve spontaneously after a few days. Available drugs do not modify the course of a viral cold; 2) Some drugs used to treat colds carry a risk of serious adverse effects. This includes nasal sprays, especially ... Read more...

Latest indexed articles for 'Nasal Decongestants - Adverse effects'

These are the very latest articles for this heading:

• Over-the-counter medications: Zicam nasal products may cause loss of sense of smell... 30 Aug 2009
• [Pollen allergy and pregnancy. A literature review of anti-allergic agents shows no increased risk of fetal injuries] 30 May 2009
• Parental misinterpretations of over-the-counter pediatric cough and cold medication labels. 30 May 2009
• WITHDRAWN: Nasal decongestants for the common cold. 13 Apr 2009
• Exanthematic reaction to pseudoephedrine. 27 Feb 2009
• [Sinusitis] 2 Feb 2009
• The common cold. 30 Jan 2009
• Misuse of over-the-counter cough or cold medications among adolescents: prevalence and correlates in a national sample. 2 Jan 2009
• OTC article makes headlines. 30 Dec 2008
• Diagnosis and management of nasal congestion: the role of intranasal corticosteroids. 30 Dec 2008
• Maternal vasoactive exposures, amniotic bands, and terminal transverse limb defects. 30 Dec 2008
• Rhinitis medicamentosa: what an otolaryngologist needs to know. 17 Dec 2008
• Pseudoephedrine use among US children, 1999-2006: results from the Slone survey. 29 Nov 2008
• Debate continues over the safety of cold and cough medicines for children. 24 Nov 2008
• [Nasal decongestants and nasal sprays in children] 18 Nov 2008
• Toxicity and use of over-the-counter cough and cold medication in the pediatric population. 30 Oct 2008
• Revised product labels for pediatric over-the-counter cough and cold medicines. 29 Oct 2008
• OTC, DTC, a stuffy nose, cocaine, and methamphetamine. 30 Aug 2008
• Intraoperative dilated pupil during nasal polypectomy. 6 Aug 2008
• [Do we practice too uncritical prescription of phenylpropanolamine?] 30 Jul 2008

See a longer list of these articles.

Technical information about 'Nasal Decongestants'

Definition: Drugs designed to treat inflammation of the nasal passages, generally the result of an infection (more often than not the common cold) or an allergy related condition, e.g., hay fever. The inflammation involves swelling of the mucous membrane that lines the nasal passages and results in inordinate mucus production. The primary class of nasal decongestants are vasoconstrictor agents. (From PharmAssist, The Family Guide to Health and Medicine, 1993)

Registry Number: 0

Descriptor UI: D014663

Alternative terms: Nasal Decongestants; Decongestants, Nasal; Decongestants; Vasoconstrictor Agents, Nasal; Agents, Nasal Vasoconstrictor; Nasal Vasoconstrictor Agents; Vasoconstrictors, Nasal; Nasal Vasoconstrictors;

Allowable Qualifiers: administration & dosage; adverse effects; analysis; antagonists & inhibitors; blood; cerebrospinal fluid; chemical synthesis; classification; diagnostic use; economics; history; immunology; isolation & purification; metabolism; pharmacokinetics; pharmacology; poisoning; radiation effects; standards; supply & distribution; therapeutic use; toxicity; urine; chemistry; contraindications; agonists;

Tree Number: D27.505.954.411.793.610; D27.505.954.796.560;

History Note: 96; was VASOCONSTRICTOR AGENTS, NASAL 1967-95; NASAL DECONGESTANTS was see VASOCONSTRICTOR AGENTS, NASAL 1967-95

Technical Notes: Nasal Decongestants - do not use entry term VASOCONSTRICTOR AGENTS, NASAL for the nasal administration of systemic vasoconstrictor agents; use instead the specific vasoconstrictor agent / admin + ADMINISTRATION, INTRANASAL